Conclusion
In this heart failure cohort of patients with high prevalence of Chagas
disease cardiomyopathy, survival was less-favorable in patients
undergoing CRT upgrade compared to de novo implantations. Until
further evidence is available, this result should be taken into account
when evaluating upgrade therapy in Chagas disease patients with previous
ventricular pacing.